raltegravir O-methyl imp

Raltegravir O-methyl impurity is a structurally related API impurity arising from methylation at the oxygen atom of the ester functionality in the parent drug's naphthyridine core. This impurity retains the bicyclic heteroaromatic framework of raltegravir but features an O-methyl substitution, altering the electronic and steric properties of the ester moiety. The modification introduces a methylated ether linkage, which may impact pharmacokinetic stability and analytical detection profiles. This compound serves as a critical HPLC reference standard for quantifying process-derived impurities in raltegravir formulations.